Titlebook: Brain Metastasis; Leonard Weiss,Harvey A. Gilbert,Jerome B. Posner Book 1980 G.K. Hall & Co. 1980 Nervous System.brain.brain tumor.carcino

Geyser

Radionuclide Imaging of Cancer Metastases in the Brainy the tumors. The normal brain is delineated in such images because the traditional radiopharmaceuticals (human serum albumin, mercuhydrin, sodium pertechnetate, .Tc-DTPA) do not pass the blood-brain barrier. Normal muscular, skeletal and glandular structures adjacent to the brain are visible and ma

cinder

Positron-Emission Tomographyd biochemical changes. Although some such information is currently available from various animal models, the conflicting nature of these data often leaves many important questions unanswered and emphasizes the immense difficulty of developing and studying laboratory models of human disease. One obvi

能夠支付

Analysis of the Benefit of Palliation of Brain Metastaseseurologic dysfunction; the concomitant presentation of brain metastasis and a primary lesion (often lung cancer); as a first sign of dissemination after a period of time with no evidence of disease. Regardless of these or other circumstances, the patient most often realizes the prognostic significan

finite

The Memorial Hospital Experiencethe literature contained scanty information regarding the beneficial effects of irradiation for intracranial metastases. Since there was insufficient experience to guide us, we had to proceed cautiously. It was decided that the whole brain needed to be irradiated because intracranial metastases are

tenuous

光亮

vasculitis

AUGER

infelicitous

https://doi.org/10.1007/978-1-4899-7641-3ussed and illustrated by a comparison of local and systemic drug administration. Third, current studies using a metastatic brain tumor model and quantitative autoradiography demonstrate considerable variability in the permeability of tumor capillaries and a reduction in blood flow through a metastatic tumor in comparison to normal brain regions.

全國性

E. Karampotsis,G. Dounias,J. Jantzenous alternative is to develop a means by which the hemodynamic, biochemical and metabolic bases of cerebral disease can be safely studied sequentially in humans by using externally detected radiolabeled tracers.